drugset / Trial / NCT01942551

Safety and Pharmacokinetic Interaction Study of Tadalafil and Dutasteride

NCT01942551

Phase 1 Completed 47 enrolled Dongkook Pharmaceutical Co., Ltd.
Non-randomizedCrossoverOpen-label

Summary

This is an open-label, two-arm, one-sequence, cross-over study to evaluate the safety and pharmacokinetic interaction after oral concomitant administration of tadalafil and dutasteride in healthy male volunteers.

Timeline

Start
2013-09
Primary completion
2013-12
Completion
2013-12

Drugs

EvaluationDrugModalityDoseRoute
Subject Dutasteride Small molecule Oral
Subject Tadalafil Small molecule Oral